By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Proteostasis Therapeutics, Inc. 

200 Technology Square
Suite 402
Cambridge  Massachusetts  02139  U.S.A.
Phone: n/a Fax: n/a



Company News
Proteostasis (PTI) Appoints Naimish Patel, M.D., C.M., And Elizabeth Tullis, M.D., FRCPC, To Its Clinical Advisory Board 9/28/2016 7:36:27 AM
Proteostasis (PTI) Announces Scientific Presentations On New Data At 30th Annual North American Cystic Fibrosis Conference 9/22/2016 10:13:23 AM
Proteostasis (PTI) To Present At Upcoming Investor Conferences 9/16/2016 8:02:22 AM
Proteostasis (PTI) Announces Closing Of Follow-On Public Offering Of Common Stock 9/15/2016 9:04:21 AM
Proteostasis (PTI) Announces Pricing Of Public Offering Of Common Stock 9/9/2016 7:36:52 AM
Proteostasis (PTI) Achieves Preclinical Milestone In Astellas (ALPMY) Collaboration 8/9/2016 11:12:04 AM
Proteostasis (PTI) Announces Key Leadership Appointments 8/8/2016 9:48:55 AM
Proteostasis (PTI) Presents New Data Demonstrating Potential For Genotype-Agnostic And Combination Therapies For People With Cystic Fibrosis 4/1/2016 8:37:21 AM
Proteostasis (PTI) Debuts Well-Below Expected Range But Still Raises $50 Millon in IPO 2/11/2016 8:11:17 AM
Proteostasis Files for a $86 Million IPO 12/28/2015 7:34:34 AM